ClinicalTrials.gg
Not yet recruitingNCT06999473Updated May 31, 2025

Assessment and Treat Neglect Patients With a VR Application

An interventional study of Virtual reality training and physiotherapy and occupational therapy in Neglect, Hemispatial, Stroke and Virtual Reality Therapy, sponsored by Universiteit Antwerpen. Not yet recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-31.

Sponsored by Universiteit Antwerpen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this project is to investigate the effectiveness of neglect training in our self-developed VR application "SpatialSense". The investigators aim to reach the following goals:

i. Compare conventional neglect therapy for neglect training with SpatialSense to evaluate the impacts on neglect recovery to see whether the VR therapy improves the clinical outcomes, such as balance recovery, perception of verticality, quality of life, independence in daily activities, and cognitive impairment, after rehabilitation training.

ii. Analyze and compare the search strategies employed by stroke patients with VSN and those without VSN during the execution of the search task with SpatialSense to summarize typical visual scanning strategies for facilitation, rehabilitation training, and improving the transfer effect in daily activities.

The experimental group will receive both conventional OT and PT treatment, but 3 days a week, half an hour of conventional treatment will be replaced by treatment with SpatialSense software. The control group will receive their regular dose-matched conventional OT and PT sessions without interference. The experimental group will receive SpatialSense training 3 times a week for a consecutive 4 weeks (12 sessions in total of 30 minutes).

Read the detailed description

Technical information: Our VR application is made with the game engine Unity (version 2020.2.5f1). We built this for the HMD Pico 4 Enterprise, which has six degrees of freedom, a 4K RGB display, a 101-degree field of view, and built-in eye-tracking hardware and software. The virtual environment is a 3-dimensional immersive environment in which the participant will be placed in three different virtual scenes: a picnic table, a kitchen, and a playground. This allows for the placement of stimuli in three different regions: near peripersonal (reaching) space, far peripersonal space, and extrapersonal (far) space. The goal of the game is to search for items that appear in front of the view, as accurately and quickly as possible.

02

Conditions studied

  • Neglect, Hemispatial
  • Stroke
  • Virtual Reality Therapy
03

In context

Perceptual Disorders

93 studies on the registry are indexed under Perceptual Disorders; 24 are open to participants now.

This study's planned enrollment of 30 is close to the median of 30 across 70 interventional studies indexed under Perceptual Disorders.

Browse Perceptual Disorders studies →

Lead sponsor

Universiteit Antwerpen is the lead sponsor of 132 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 years or older
  2. Able to provide informed consent
  3. have had a hemispheric stroke

Exclusion criteria

Exclusion Criteria:

  1. Have a severe comorbid psychiatric (E.g. psychotic symptoms) disorder
  2. Have a premorbid neurodegenerative disease (E.g. Alzheimer's dementia, vascular dementia)
  3. Have severe written language comprehension deficits
  4. Have a medical implant, such as a cochlear implant or a pacemaker
  5. Have a severe visual impairment that cannot be corrected by wearing glasses while training
  6. Have a history of epileptic seizures The following exclusion criteria do not apply to the Non-VSN stroke group.
  7. Do not show signs of a spatial asymmetry in performance on a battery of screening tasks
  8. Having visual field deficits or lesions in the occipital lobe
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    VR group

    The experimental group will receive both conventional OT and PT treatment but 3 days a week, half an hour of conventional treatment will be replaced by treatment with SpatialSense software. The experimental group will receive SpatialSense training 3 times a week for a consecutive 4 weeks (12 sessions in total of 30 minutes).

    Device: Virtual reality training · Behavioral: physiotherapy and occupational therapy · Device: Assessment

  • Active comparator
    Conventional

    The control group will have the assessment on SpatialSense and then receive their regular dose-matched conventional OT and PT sessions without interference. All people with stroke receive conventional occupational (OT) and physical therapy (PT) for 1 hour each. In a total of 4 weeks, 5 times a week.

    Behavioral: physiotherapy and occupational therapy · Device: Assessment

  • Other
    Non-neglect stroke group

    Prior to the assessment in SpatialSense, the screen of the head-mounted display will be projected onto a laptop and the eye tracking will be calibrated to the participants' eye positions by the investigator. Then, all participants will perform the assessment part in SpatialSense. During assessments with SpatialSense, participants will sit in a wheelchair or on a straight-back chair. The trunk will be restricted to the chair. Finally, the data will be exported from SpatialSense and analyzed by investigators to define different search strategies while performing scanning tasks.

    Device: Assessment

Interventions

  • DeviceVirtual reality training

    This training is built for the HMD Pico 4 Enterprise, which has six degrees of freedom, a 4k RGB display, a 101-degree field of view, and built-in eye-tracking hardware and software. The virtual environment is a 3-dimensional immersive environment in which the participant will be placed in three different virtual scenes: a picnic table, a kitchen, and a playground. This allows for the placement of stimuli in three different regions: near peripersonal (reaching) space, far peripersonal space, and extrapersonal (far) space. The goal of the game is to search for items that appear in front of the view, as accurately and quickly as possible.

  • Behavioralphysiotherapy and occupational therapy

    The conventional treatment consists of a problem-solving approach mainly based on the neurodevelopmental treatment approach. For VSN, the conventional treatment mainly consists of a mix of prism adaptation, visual scanning, and compensatory strategies based on the individual needs of the patient.

  • DeviceAssessment

    During assessments with SpatialSense, participants will sit in a wheelchair or on a straight-back chair. The trunk will be restricted to the chair. Finally, the data will be exported from SpatialSense and analyzed by investigators to define different search strategies while performing scanning tasks.

06

What researchers measure

Primary outcomes

  1. Change in searching performance and visuospatial neglect

    The Broken Hearts Cancellation Test is a paper-and-pencil assessment used to measure searching performance and spatial neglect. Participants are asked to identify and cancel out complete heart shapes among distractor stimuli (broken hearts) within a fixed time frame. Performance is evaluated based on the number of correct cancellations and errors (false positives and omissions). The total score is calculated as: Total Correct Hits: Number of correctly cancelled complete hearts (max score: 50) Errors: Number of incorrectly marked broken hearts or missed targets Higher total correct scores indicate better performance. Improvement is defined as an increase in correct hits and/or a reduction in errors.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

Secondary outcomes

  1. Change in visuospatial neglect

    The Schenkenberg Line Bisection Test assesses visuospatial neglect by requiring participants to mark the perceived midpoint of horizontal lines printed on a sheet. The test evaluates the presence and severity of spatial attention deficits, particularly following brain injury or stroke. Performance is quantified as the average deviation (in millimeters) from the true midpoint of each line: Positive values indicate a rightward deviation Negative values indicate a leftward deviation A score closer to 0 mm indicates better spatial accuracy

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  2. Change in functional neglect symptoms

    The Catherine Bergego Scale (CBS) is a standardized observational tool used to assess the presence and severity of unilateral spatial neglect in activities of daily living. A set of 10 real-life tasks (e.g., grooming, navigating through doorways) will be scored from 0 to 3: 0 = No neglect 1. = Mild neglect 2. = Moderate neglect 3. = Severe neglect The total score ranges from 0 to 30, with higher scores indicating more severe neglect.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  3. Change in visual search reaction time

    The Computerized Visual Search Time Test assesses visual attention and processing speed by requiring participants to locate and identify a target stimulus among distractors on a computer screen. The test records the response time (in milliseconds) needed to correctly identify the target. Shorter reaction times indicate better visual processing and attention.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  4. Change in spatial and searching performance

    To assess neglect in our application, we will extract Embedded game parameters from SpatialSense, the maximal rightward angle is compared with the maximal leftward angle on low, medium, and high difficulty levels: the trajectory of the gaze ray (GR), head movement (HR), and eye movement (ER). The maximum angles are added to form the search area middle (SAM) which should be close to 0. A positive SAM indicates the participant searched further to the right than to the left, and a negative SAM means the participant searched further to the left than to the right.

    Time frame: Baseline (Day 1) and End of Study (Day 30). Through study completion, an average of 7days

  5. Change in trunk control

    The Trunk Impairment Scale (TIS) assesses motor impairment of the trunk after neurological injury, especially stroke. It includes three subscales: Static Sitting Balance (0-7); Dynamic Sitting Balance (0-10); Coordination (0-6). The total score ranges from 0 to 23, with higher scores indicating better trunk function and postural control.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  6. Change in balance ability

    The Berg Balance Scale (BBS) is a performance-based measure of balance and fall risk. It consists of 14 functional tasks (e.g., standing up, reaching forward, turning) that are each scored from 0 to 4, based on performance. Total score range: 0 to 56. Higher scores indicate better balance. A score below 45 is associated with increased fall risk.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

Other outcomes

  1. Change in perceived postural alignment

    The Subjective Postural Vertical (SPV) test evaluates a person's ability to perceive upright body orientation. During the assessment, the participant is seated on a tilting chair with arms folded across the chest, feet off the ground, and the trunk secured with belts. The head and legs remain free. The examiner tilts the chair at a constant speed of ±1.5°/s. The participant is asked to indicate when they perceive themselves as being in a vertical position. Performance is measured in degrees (°) of deviation from true vertical. Lower deviation values indicate better accuracy in vertical perception. Normative values for SPV are approximately 0.12° ± 1.49°.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  2. Change in perceived visual verticality

    The Subjective Visual Vertical (SVV) test assesses an individual's ability to perceive gravitational vertical using visual cues. In this assessment, participants are seated 1.5 to 2 meters away from a display showing a tilted line. The examiner adjusts the line's angle until the participant indicates that it appears vertically aligned. This is commonly administered using the bucket test or a computerized visual display. Performance is measured as the angular deviation (in degrees) from true vertical. Smaller deviations indicate more accurate vertical perception. Normative SVV values typically range between -2.5° and +2.5°.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  3. Change in cognitive function

    The Mini-Mental State Examination (MMSE) is a widely used 30-point questionnaire that assesses global cognitive function. It evaluates: Orientation, Registration, Attention and calculation, Recall, Language, and Visual construction. The total score ranges from 0 to 30, with higher scores indicating better cognitive function. A score below 24 typically suggests cognitive impairment.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  4. Change in quality of life

    The SS-QOL scale is a patient-centered outcome measure designed to evaluate health-related quality of life in individuals who have experienced a stroke. This self-report instrument consists of 49 items distributed across 12 domains, including energy, upper extremity function, work/productivity, mood, self-care, social roles, family roles, vision, language, cognition, and personality. Each item is rated on a 5-point Likert scale, ranging from 1 (unable to perform the activity, requiring total assistance) to 5 (no difficulty, no assistance required). Higher scores reflect better functional outcomes.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  5. Change in functional independence

    The FIM is used to assess functional performance in essential daily living skills, including independence in self-care, sphincter control, transfers, mobility, communication, and social cognition. The instrument consists of 18 items, categorized into two subscales: motor and cognitive. Each item is rated on a 7-point ordinal scale, with scores ranging from 1 (total assistance, client expends \<25% of the effort) to 7 (complete independence). A higher score indicates a greater level of independence in performing the task related to that item. The total FIM score spans from 18 (complete dependence) to 126 (complete independence).

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  6. Change in simulator-induced symptoms

    The SSQ is a subjective assessment tool used to evaluate the severity of symptoms associated with the use of virtual reality (VR) technology. It comprises 16 items that measure three primary symptom categories: nausea, oculomotor disturbances, and disorientation. The SSQ utilizes a 4-point Likert scale, ranging from 0 (no symptoms) to 3 (severe symptoms), and symptom severity is categorized as negligible (\< 5), minimal (5-10), significant (10-15), or concerning (15-20). A total score exceeding 20 is indicative of a "poor " simulator experience.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

  7. Change in dynamic balance

    Mini-BESTest is a quantitative assessment tool for measuring balance and gait functions. It has 14 items, including 4 sections (anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait) with a maximum score of 28. Each item will be rated on a 3-point scale, with 0 indicating severe to 2 indicating normal. Higher scores indicate better balance performance.

    Time frame: Baseline (Day 1) and End of Study (Day 30)

07

Study locations

1 site
  • Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp
    Antwerp, 2610, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06999473
Responsible party
Wim Saeys (Professor, Universiteit Antwerpen) — Principal investigator
First posted
May 31, 2025
Start date
Jun 1, 2025 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
May 31, 2025

Study contacts

MENGDI LU
Contact
Mengdi.Lu@uantwerpen.be
+32 456705412
Wim Saeys
Contact
wim.saeys@uantwerpen.be
+32 496804347
Wim Saeys
study chair · +32 496804347

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion